This article refers to:
Ottaiano A, Capozzi M, De Divitiis C, De Stefano A, Botti G, Avallone A and Tafuto S. Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials. Acta Oncol. 2017. DOI: 10.1080/0284186X.2017.1288922
When the above article was first published online, the corresponding author was listed in error as Alessandro Ottaiano. This has now been corrected to Antonio Avallone, [email protected], Department of Abdominal Oncology, National Cancer Institute ‘G. Pascale’, Naples, Italy.
The authors apologise for this error.